PEAK1 and ovarian cancer: Our results showed that CDC5L (without 3′‐UTR) overexpression reversed the inhibition of malignant behaviors of ovarian cancer cells by miR‐542‐3p and increased the expression levels of PEAK1, p‐ERK1/2, and p‐JAK2.